DK1947104T3 - Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C - Google Patents

Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C

Info

Publication number
DK1947104T3
DK1947104T3 DK08000552.3T DK08000552T DK1947104T3 DK 1947104 T3 DK1947104 T3 DK 1947104T3 DK 08000552 T DK08000552 T DK 08000552T DK 1947104 T3 DK1947104 T3 DK 1947104T3
Authority
DK
Denmark
Prior art keywords
characterization
compositions
identification
methods
hcv
Prior art date
Application number
DK08000552.3T
Other languages
English (en)
Inventor
Carol Holland-Staley
Original Assignee
Lab 21 Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lab 21 Ltd filed Critical Lab 21 Ltd
Application granted granted Critical
Publication of DK1947104T3 publication Critical patent/DK1947104T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • C12Q1/706—Specific hybridization probes for hepatitis
    • C12Q1/707—Specific hybridization probes for hepatitis non-A, non-B Hepatitis, excluding hepatitis D

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DK08000552.3T 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C DK1947104T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36360302P 2002-03-11 2002-03-11
EP03714097A EP1490383B1 (en) 2002-03-11 2003-03-11 Methods and compositions for identifying and characterizing hepatitis c

Publications (1)

Publication Number Publication Date
DK1947104T3 true DK1947104T3 (da) 2012-08-06

Family

ID=28041784

Family Applications (3)

Application Number Title Priority Date Filing Date
DK08000552.3T DK1947104T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identifikation og karakterisering af hepatitis C
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK03714097T DK1490383T3 (da) 2002-03-11 2003-03-11 Fremgangsmåde og sammensætning til identifikation og karakterisering af hepatitis C
DK08014584.0T DK2014671T3 (da) 2002-03-11 2003-03-11 Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C

Country Status (9)

Country Link
US (3) US20070172926A1 (da)
EP (3) EP1490383B1 (da)
AT (3) ATE423785T1 (da)
AU (2) AU2003218111B8 (da)
DE (2) DE60332781D1 (da)
DK (3) DK1947104T3 (da)
ES (3) ES2346717T3 (da)
PT (3) PT1947104E (da)
WO (1) WO2003077729A2 (da)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2346717T3 (es) 2002-03-11 2010-10-19 Lab 21 Limited Metodo y composiciones para identificar y caracterizar la hepatitis c.
WO2006110762A2 (en) * 2005-04-11 2006-10-19 Achillion Pharmaceutical compositions for and methods of inhibiting hcv replication
WO2007042827A2 (en) * 2005-10-14 2007-04-19 Ivan Petyaev Treatment and diagnosis of obligate intracellular pathogens
CN100365124C (zh) * 2005-10-27 2008-01-30 云南大学 一段丙型肝炎病毒特异性cDNA序列的应用
US20090082344A1 (en) * 2006-07-13 2009-03-26 Searete Llc Methods and systems for treating disease
US20080015835A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for treating disease
US20080014572A1 (en) * 2006-07-13 2008-01-17 Searete Llc, A Limited Liability Corporation Of The State Of Delaware Methods and systems for molecular inhibition
EP2527474A1 (en) 2006-10-20 2012-11-28 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS3/4A genomic region
EP2463390A1 (en) 2006-10-20 2012-06-13 Innogenetics N.V. Methodology for analysis of sequence variations within the HCV NS5B genomic region
AU2008318618A1 (en) * 2007-10-30 2009-05-07 Intermune, Inc. HCV genotyping and phenotyping
JP5607532B2 (ja) * 2007-10-31 2014-10-15 デバイオファーム エスエイ Ｈｃｖ薬剤抵抗性のほぼ全ゲノムのアッセイ
WO2011151405A1 (en) 2010-06-04 2011-12-08 Institut National De La Sante Et De La Recherche Medicale (Inserm) Constitutively active prolactin receptor variants as prognostic markers and therapeutic targets to prevent progression of hormone-dependent cancers towards hormone-independence
EP2721183A4 (en) 2011-06-20 2015-09-02 Siemens Healthcare Diagnostics REAGENTS AND METHODS OF DETECTING HCV VIRUS
AU2013205064B2 (en) * 2012-06-04 2015-07-30 Gen-Probe Incorporated Compositions and Methods for Amplifying and Characterizing HCV Nucleic Acid

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
JPH02500880A (ja) 1987-11-18 1990-03-29 カイロン　コーポレイション Ｎａｎｂｖの診断用薬およびワクチン
US5350671A (en) 1987-11-18 1994-09-27 Chiron Corporation HCV immunoassays employing C domain antigens
US5372928A (en) * 1989-09-15 1994-12-13 Chiron Corporation Hepatitis C virus isolates
EP0435229A1 (en) * 1989-12-27 1991-07-03 Sanwa Kagaku Kenkyusho Co., Ltd. DNA of non-A, non-B hepatitis virus gene, its clone and use thereof
US5747339A (en) * 1990-06-25 1998-05-05 Research Foundation For Microbial Diseases Of Osaka Non-A, non-B hepatitis virus genomic CDNA and antigen polypeptide
ES2188583T3 (es) * 1991-06-24 2003-07-01 Chiron Corp Polipeptidos para el virus de la hepatitis c (hcv).
US20030125270A1 (en) * 2000-12-18 2003-07-03 Lawrence Blatt Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
EP0984068B1 (en) * 1993-04-27 2012-03-28 Innogenetics N.V. Sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents
EP0698101B1 (en) * 1993-05-05 2004-11-03 Common Services Agency Hepatitis-c virus type 4, 5 and 6
US5571673A (en) * 1994-11-23 1996-11-05 Hoffmann-La Roche Inc. Methods for in-solution quenching of fluorescently labeled oligonucleotide probes
US6127116A (en) * 1995-08-29 2000-10-03 Washington University Functional DNA clone for hepatitis C virus (HCV) and uses thereof
US6242187B1 (en) * 1996-01-29 2001-06-05 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US7338759B1 (en) * 1997-03-04 2008-03-04 Washington University HCV variants
US6153421A (en) * 1997-07-18 2000-11-28 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Cloned genomes of infectious hepatitis C viruses and uses thereof
CA2298102A1 (en) * 1997-07-30 1999-02-11 Virologic, Inc. Compositions and methods for determining anti-viral drug susceptibility and resistance and anti-viral drug screening
US6280940B1 (en) * 1998-08-05 2001-08-28 Agouron Pharmaceuticals, Inc. Reporter gene system for use in cell-based assessment of inhibitors of the Hepatitis C virus protease
ATE526423T1 (de) * 2000-04-18 2011-10-15 Virco Bvba Verfahren zum messen des medikamentenwiderstands gegen hcv
DK1296998T3 (da) * 2000-05-23 2011-12-12 Univ Washington HCV-varianter
WO2002008447A2 (en) * 2000-07-24 2002-01-31 Institute Of Molecular & Cell Biology Nucleic acids and methods for detecting viral infection, uncovering anti-viral drug candidates and determining drug resistance of viral isolates
US6680059B2 (en) * 2000-08-29 2004-01-20 Tripep Ab Vaccines containing ribavirin and methods of use thereof
ES2346717T3 (es) 2002-03-11 2010-10-19 Lab 21 Limited Metodo y composiciones para identificar y caracterizar la hepatitis c.

Also Published As

Publication number Publication date
US8173795B2 (en) 2012-05-08
AU2008249300B2 (en) 2012-08-16
PT1947104E (pt) 2012-08-09
ATE469162T1 (de) 2010-06-15
EP1490383A4 (en) 2005-12-21
DE60326327D1 (de) 2009-04-09
ATE423785T1 (de) 2009-03-15
EP1947104A3 (en) 2009-04-08
AU2003218111A1 (en) 2003-09-29
DK1490383T3 (da) 2009-06-08
EP1947104A2 (en) 2008-07-23
EP2014671B1 (en) 2010-05-26
EP1490383B1 (en) 2009-02-25
ATE556084T1 (de) 2012-05-15
ES2386742T3 (es) 2012-08-28
US20120322051A1 (en) 2012-12-20
AU2003218111B2 (en) 2008-11-06
ES2321498T3 (es) 2009-06-08
EP1947104B1 (en) 2012-05-02
US20070172926A1 (en) 2007-07-26
WO2003077729A9 (en) 2004-04-22
AU2008249300A1 (en) 2008-12-18
PT2014671E (pt) 2010-06-16
DK2014671T3 (da) 2010-09-20
EP1490383A2 (en) 2004-12-29
US20090047663A1 (en) 2009-02-19
WO2003077729A3 (en) 2004-06-03
EP2014671A1 (en) 2009-01-14
WO2003077729A2 (en) 2003-09-25
AU2003218111B8 (en) 2008-11-20
DE60332781D1 (de) 2010-07-08
PT1490383E (pt) 2009-05-25
ES2346717T3 (es) 2010-10-19

Similar Documents

Publication Publication Date Title
DK2014671T3 (da) Fremgangsmåder og sammensætninger til identificering og karakterisering af hepatitis C
ATE440965T1 (de) Neue zusammensetzung und methode zur 'hot start' nukleinsäureamplifizierung
ATE432365T1 (de) Verfahren, kits und reagenzien zur nukleinsäuresequenzierung
DK1026262T3 (da) Oligonukleotidprimere til effektiv detektering af hepatitis C-virus (HCV) og fremgangsmåder til anvendelse deraf
DK1218542T3 (da) Fremgangsmåder og sammensætninger til lineær isotermisk amplifikation af polynukleotidsekvenser
EP1735465A4 (en) Compositions for use in identification of viral hemorrhagic fever viruses
ATE317916T1 (de) Verfahren zur identifizierung von adeno- assoziiertem virus (aav) sequenzen sowie kit zur ausführung der methode
DK1423400T3 (da) Evolution af hidtil ukendt molekylfunktion
EP2272952B8 (en) Thermostable or thermoactive DNA polymerase with attenuated 3'-5' exonuclease activity
DK1507002T3 (da) Termostabilt Taq-polymerasefragment
ATE397092T1 (de) Methode zur direkten sequenzierung von nukleinsäuren
DE60143314D1 (de) Estimmung der präsenz von cryptosporidium organismen in einer testprobe
WO2001025483A3 (en) Compositions for dna amplification, synthesis, and mutagenesis
MXPA01009698A (es) Desdoblamiento de acidos nucleicos de soportes solidos.
ATE427362T1 (de) Polymorphe marker des lsr-gens
EP2180051A3 (en) Method for detecting and quantifying endogenous wheat DNA sequence
DE60229966D1 (de) Diabetesmodell
IL195194A0 (en) Thermostable dna polymerase of the archaeal ampullavirus abv and its applications
DK1036847T3 (da) Oligonukleotidprimere til effektiv revers transskription af Hepatitis C Virus (HCV)-RNA og fremgangsmåde til anvendelse deraf
ATE414175T1 (de) Detektion von rpob sequenzen von mycobacterium tuberculosis